FDA Promises Interchangeability For Alvotech’s 100mg/ml Humira Rival – If It Passes Inspection

April 2023 Approval For AVT02 Adalimumab Biosimilar Hinges On Facility Nod

 
• By David Wallace
  
13 April Calendar
The FDA goal date for AVT02 is 13 April 2023 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products